Premier Inc

PINC

Equity

ISIN US74051N1028 / Valor 22227168

NASDAQ (2024-09-18)

USD 20.48-0.24%

Premier Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Premier Inc. is a healthcare improvement company that brings together a vast network of U.S. hospitals, health systems, providers, and organizations to drive better outcomes and efficiency in the healthcare industry. With a focus on responding to regulatory changes and implementing policies for Medicare Advantage and Medicare Prescription Drug Benefit programs, Premier Inc. plays a crucial role in shaping the future of healthcare delivery in the United States.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Premier Inc reported total net revenue of $342.6 million for the fiscal-year 2024 third quarter, which represents a 6% increase over the prior-year period. This growth was driven by both the Supply Chain Services and Performance Services segments.

Net Loss

For the fiscal-year 2024 third quarter, Premier Inc reported a GAAP net loss of $49.2 million, or $(0.36) per fully diluted share. This loss includes a $140.1 million impairment related to the company's Contigo Health business.

Adjusted Earnings

Premier Inc's adjusted earnings per share (EPS) for the fiscal-year 2024 third quarter remained flat at $0.55 compared to the prior-year period. This stability in adjusted EPS reflects the company's efforts to manage profitability despite challenges.

Segment Performance

In the fiscal-year 2024 third quarter, Premier Inc's Supply Chain Services segment net revenue increased by 5% to $227.7 million, while the Performance Services segment saw a 9% increase in net revenue to $115.0 million. These gains were driven by higher administrative fees and software license revenues.

Fiscal 2024 Guidance

Premier Inc reaffirmed its fiscal 2024 financial guidance, projecting total net revenue in the range of $1.265 billion to $1.325 billion. The company also expects adjusted EBITDA to be between $405 million and $425 million, and adjusted EPS to range from $2.06 to $2.18.

Summarized from source with an LLMView Source

Key figures

-6.70%1Y

-47.5%3Y

-43.3%5Y

Performance

22.5%1Y

25.7%3Y

29.4%5Y

Volatility